Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Modulation of Cognitive, Affective, and Motor Function by Transcranial Direct Current Stimulation as Co-adjuvant Therapy in Parkinson's Disease.

NCT01113086 is registered in ClinicalTrials.gov with Spaulding Rehabilitation Hospital as lead sponsor.

NCT NCT01113086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01113086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Modulation of Cognitive, Affective, and Motor Function by Transcranial Direct Current Stimulation as Co-adjuvant Therapy in Parkinson's Disease.
Lead sponsor
Spaulding Rehabilitation Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2009
Completion date
March 31, 2013
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease